RxSight News

RxSight Analyst Ratings

BenzingaApr 11 05:49 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), RxSight (RXST) and Clearside Biomedical (CLSD)

TipRanksApr 11 05:50 ET

Patrick Wood Reaffirms Buy Rating for RxSight Amid Strong Growth and Market Expansion Potential

TipRanksMar 4 14:05 ET

RxSight Analyst Ratings

BenzingaFeb 29 10:49 ET

Oppenheimer Adjusts RxSight Price Target to $61 From $54, Maintains Outperform Rating

MT NewswiresFeb 29 09:35 ET

Oppenheimer Reaffirms Their Buy Rating on RxSight (RXST)

TipRanksFeb 29 08:06 ET

Buy Rating on RxSight: Strong Financials and Positive 2024 Outlook Drive Upward Price Target

TipRanksFeb 29 06:26 ET

Analysts Are Bullish on Top Healthcare Stocks: RxSight (RXST), Personalis (PSNL)

TipRanksFeb 29 05:20 ET

RxSight (RXST) Gets a Buy From BTIG

TipRanksFeb 22 05:25 ET

Analysts' Top Healthcare Picks: RxSight (RXST), Adaptive Biotechnologies (ADPT)

TipRanksFeb 20 06:20 ET

RxSight Analyst Ratings

BenzingaFeb 12 09:43 ET

RxSight Analyst Ratings

BenzingaJan 29 13:46 ET

Oppenheimer Raises RxSight Price Target to $54 From $50, Maintains Outperform Rating

MT NewswiresJan 29 09:14 ET

RxSight Analyst Ratings

BenzingaJan 16 10:31 ET

Oppenheimer Raises RxSight Price Target to $50 From $46, Maintains Outperform Rating

MT NewswiresJan 16 09:39 ET

RxSight Analyst Ratings

BenzingaJan 8 13:10 ET

Oppenheimer Ups Price Target on RxSight to $46 From $38, Maintains Outperform Rating

MT NewswiresJan 8 09:25 ET

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Ultragenyx Pharmaceutical (RARE) and Inspire Medical Systems (INSP)

TipRanksJan 8 08:00 ET

RxSight (RXST) Initiated With a Buy at Stifel Nicolaus

TipRanksJan 8 07:46 ET

RxSight Earns Buy Rating on Stellar Financial Performance and Promising Market Outlook

TipRanksJan 8 07:15 ET